ATE368104T1 - Verbesserte nukleinsäure-modifizierende enzyme - Google Patents

Verbesserte nukleinsäure-modifizierende enzyme

Info

Publication number
ATE368104T1
ATE368104T1 AT01941707T AT01941707T ATE368104T1 AT E368104 T1 ATE368104 T1 AT E368104T1 AT 01941707 T AT01941707 T AT 01941707T AT 01941707 T AT01941707 T AT 01941707T AT E368104 T1 ATE368104 T1 AT E368104T1
Authority
AT
Austria
Prior art keywords
nucleic acid
modifying enzymes
acid modifying
improved nucleic
enzyme
Prior art date
Application number
AT01941707T
Other languages
English (en)
Inventor
Yan Wang
Original Assignee
Bio Rad Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories filed Critical Bio Rad Laboratories
Application granted granted Critical
Publication of ATE368104T1 publication Critical patent/ATE368104T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01941707T 2000-05-26 2001-05-29 Verbesserte nukleinsäure-modifizierende enzyme ATE368104T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20756700P 2000-05-26 2000-05-26
US09/640,958 US6627424B1 (en) 2000-05-26 2000-08-16 Nucleic acid modifying enzymes

Publications (1)

Publication Number Publication Date
ATE368104T1 true ATE368104T1 (de) 2007-08-15

Family

ID=26902363

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01941707T ATE368104T1 (de) 2000-05-26 2001-05-29 Verbesserte nukleinsäure-modifizierende enzyme

Country Status (10)

Country Link
US (10) US6627424B1 (de)
EP (1) EP1283875B1 (de)
JP (2) JP4405725B2 (de)
AT (1) ATE368104T1 (de)
AU (2) AU2001275039B2 (de)
CA (1) CA2409417C (de)
DE (1) DE60129549T2 (de)
DK (1) DK1283875T3 (de)
ES (1) ES2291322T3 (de)
WO (1) WO2001092501A1 (de)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123940A1 (en) * 1999-10-29 2005-06-09 Stratagene California Compositions and methods for synthesizing cDNA
US20030228616A1 (en) * 1999-10-29 2003-12-11 Stratagene DNA polymerase mutants with reverse transcriptase activity
US20040009486A1 (en) * 1999-10-29 2004-01-15 Sorge Joseph A. Compositions and methods utilizing DNA polymerases
US8268605B2 (en) 1999-10-29 2012-09-18 Agilent Technologies, Inc. Compositions and methods utilizing DNA polymerases
EP1259624B1 (de) * 2000-02-17 2008-05-14 Qiagen GmbH Thermostabile chimäre nucleinsäurepolymerasen und ihre verwendungen
US6627424B1 (en) * 2000-05-26 2003-09-30 Mj Bioworks, Inc. Nucleic acid modifying enzymes
DE10049211A1 (de) * 2000-10-05 2002-04-18 Qiagen Gmbh Thermostabile Polymerase aus Thermococcus pacificus
AU2002227156A1 (en) 2000-12-01 2002-06-11 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
WO2003046149A2 (en) * 2001-11-28 2003-06-05 Mj Bioworks Incorporated Methods of using improved polymerases
US7163790B2 (en) * 2001-11-28 2007-01-16 Bio-Rad Laboratories, Inc. Parallel polymorphism scoring by amplification and error correction
US20060234227A1 (en) * 2002-05-14 2006-10-19 Alexei Slesarev Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes
US7560260B2 (en) * 2002-07-25 2009-07-14 Bio-Rad Laboratories, Inc. Compositions with polymerase activity
WO2004011605A2 (en) 2002-07-25 2004-02-05 Mj Bioworks Incorporated Hybrid protein methods and compositions
US7666645B2 (en) * 2002-10-23 2010-02-23 Bio-Rad Laboratories, Inc. Sso7-polymerase conjugate proteins
US8283148B2 (en) 2002-10-25 2012-10-09 Agilent Technologies, Inc. DNA polymerase compositions for quantitative PCR and methods thereof
JP2006507012A (ja) * 2002-10-25 2006-03-02 ストラタジーン カリフォルニア 減少した塩基類似体検出活性を有するｄｎａポリメラーゼ
US7960157B2 (en) * 2002-12-20 2011-06-14 Agilent Technologies, Inc. DNA polymerase blends and uses thereof
JP4722035B2 (ja) * 2003-03-25 2011-07-13 アジレント・テクノロジーズ・インク Ｄｎａポリメラーゼ融合物およびその使用
US7417133B2 (en) * 2004-02-27 2008-08-26 Institut Pasteur Methods for obtaining thermostable enzymes, DNA polymerase I variants from Thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same
EP3489257A1 (de) * 2004-07-23 2019-05-29 Acceleron Pharma Inc. Actrii-rezeptor-polypeptide, verfahren und zusammensetzungen
US20060105348A1 (en) * 2004-11-15 2006-05-18 Lee Jun E Compositions and methods for the detection and discrimination of nucleic acids
AU2006203970A1 (en) * 2005-01-06 2006-07-13 Applied Biosystems, Llc. Polypeptides having nucleic acid binding activity
EP1836319B1 (de) * 2005-01-06 2012-09-19 Life Technologies Corporation Polypeptide mit nukleinsäurebindender aktivität sowie verfahren zur nukleinsäureamplifikation
WO2007050125A2 (en) * 2005-05-27 2007-05-03 William Marsh Rice University High processivity polymerases
US20070117114A1 (en) * 2005-07-07 2007-05-24 Quanta Biosciences, Inc. Compositions and methods for increasing amplification efficiency
EP1910534A4 (de) * 2005-07-15 2010-03-10 Stratagene California Dna-bindungsprotein-polymerase-chimären
US20070059713A1 (en) * 2005-09-09 2007-03-15 Lee Jun E SSB-DNA polymerase fusion proteins
PT1973559E (pt) 2005-11-23 2013-02-19 Acceleron Pharma Inc Antagonistas de activina-actriia e utilizações para promover o crescimento ósseo
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
JP5106416B2 (ja) * 2006-01-06 2012-12-26 アジレント・テクノロジーズ・インク 濃縮（ｐａｃｋｅｄ）ＤＮＡポリメラーゼを含む核酸複製のための反応緩衝液組成物
US8568982B2 (en) 2006-08-09 2013-10-29 National University Of Singapore Methods of nucleic acid synthesis using particular crowding agents and concentrations
US8895016B2 (en) * 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
TWI584815B (zh) 2007-02-01 2017-06-01 艾瑟勒朗法瑪公司 活化素-ＡｃｔＲＩＩａ拮抗劑及其治療或預防乳癌之用途
TWI548647B (zh) 2007-02-02 2016-09-11 艾瑟勒朗法瑪公司 衍生自ＡｃｔＲＩＩＢ的變體與其用途
TWI606062B (zh) 2007-02-09 2017-11-21 艾瑟勒朗法瑪公司 包含ＡｃｔＲＩＩａ-Ｆｃ融合蛋白的醫藥組合物；ＡｃｔＲＩＩａ-Ｆｃ融合蛋白於治療或預防與癌症相關的骨質流失之用途；ＡｃｔＲＩＩａ-Ｆｃ融合蛋白於治療或預防多發性骨髓瘤之用途
CN107412734A (zh) 2007-09-18 2017-12-01 阿塞勒隆制药公司 活化素‑actriia拮抗剂和减少或抑制fsh分泌的用途
WO2009070604A1 (en) 2007-11-27 2009-06-04 Bio-Rad Laboratories, Inc. Reduced inhibition of one-step rt-pcr
US20110020877A1 (en) * 2008-01-11 2011-01-27 Genesys Limited Cren7 chimeric protein
GB0803628D0 (en) 2008-02-28 2008-04-02 Genesys Ltd Enzyme
GB0804722D0 (en) * 2008-03-14 2008-04-16 Genesys Ltd Enzyme
GB0804721D0 (en) * 2008-03-14 2008-04-16 Genesys Ltd Enzyme
TWI626945B (zh) 2008-08-14 2018-06-21 艾瑟勒朗法瑪公司 使用ｇｄｆ阱以增加紅血球水平
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
JP5258512B2 (ja) * 2008-10-30 2013-08-07 株式会社日立製作所 エキソヌクレアーゼ活性増強ｄｎａポリメラーゼ変異体
ES2716402T3 (es) 2008-11-03 2019-06-12 Kapa Biosystems Inc ADN polimerasas quiméricas
WO2010062777A2 (en) 2008-11-03 2010-06-03 Kapabiosystems Modified type a dna polymerases
SG172925A1 (en) 2009-01-08 2011-08-29 Bio Rad Laboratories Methods and compositions for improving efficiency of nucleic acids amplification reactions
CA2754476A1 (en) 2009-03-04 2010-09-10 Alan M. Lambowitz Stabilized reverse transcriptase fusion proteins
US9778188B2 (en) 2009-03-11 2017-10-03 Industrial Technology Research Institute Apparatus and method for detection and discrimination molecular object
WO2010111691A2 (en) 2009-03-27 2010-09-30 Life Technologies Corp Conjugates of biomolecules to nanoparticles
CA2757951A1 (en) 2009-04-10 2010-10-14 Biorad Laboratories, Inc. Modified dnase compositions and methods of use thereof
MX355042B (es) 2009-06-08 2018-04-02 Acceleon Pharma Inc Metodos para aumentar adipositos termogenicos.
CN102656187A (zh) 2009-06-12 2012-09-05 阿塞勒隆制药公司 截短的actriib-fc融合蛋白
US8889394B2 (en) * 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
CN102781518A (zh) * 2009-09-09 2012-11-14 阿塞勒隆制药公司 Actriib拮抗剂及其给药和用途
AU2010296086A1 (en) * 2009-09-16 2012-05-10 Massey University Fusion polypeptides and uses thereof
US8710016B2 (en) 2009-11-17 2014-04-29 Acceleron Pharma, Inc. ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
CN102858962A (zh) * 2009-11-19 2013-01-02 索利斯拜欧代因公司 用于增加多肽稳定性和活性的组合物及相关方法
US20110262903A1 (en) 2010-02-26 2011-10-27 Life Technologies Corporation Modified Proteins and Methods of Making and Using Same
US9482615B2 (en) 2010-03-15 2016-11-01 Industrial Technology Research Institute Single-molecule detection system and methods
US9670243B2 (en) 2010-06-02 2017-06-06 Industrial Technology Research Institute Compositions and methods for sequencing nucleic acids
US8865078B2 (en) 2010-06-11 2014-10-21 Industrial Technology Research Institute Apparatus for single-molecule detection
WO2012034007A2 (en) 2010-09-10 2012-03-15 Bio-Rad Laboratories, Inc. Size selection of dna for chromatin analysis
WO2012046140A1 (en) 2010-10-05 2012-04-12 Finnzymes Oy Enzyme mixture
KR20130132824A (ko) 2010-11-08 2013-12-05 악셀레론 파마 인코포레이티드 Actriia 결합제 및 이의 용도
WO2012097318A2 (en) 2011-01-14 2012-07-19 Kap Abiosystems Modified dna polymerases for improved amplification
US9868945B2 (en) 2011-02-08 2018-01-16 Life Technologies Corporation Linking methods, compositions, systems, kits and apparatuses
WO2012112606A1 (en) 2011-02-15 2012-08-23 Bio-Rad Laboratories, Inc. Detecting methylati0n in a subpopulation of genomic dna
WO2012125123A1 (en) 2011-03-11 2012-09-20 National University Of Singapore Pericyte progenitors from peripheral blood
SG193990A1 (en) 2011-04-08 2013-11-29 Bio Rad Laboratories Pcr reaction mixtures with decreased non-specific activity
US8715987B2 (en) 2011-05-02 2014-05-06 New England Biolabs, Inc. Solubilized phospholipids for stabilizing nucleic acid polymerases
US8921044B2 (en) 2011-05-11 2014-12-30 New England Biolabs, Inc. DNA polymerase variants with reduced exonuclease activity and uses thereof
EP2707481B1 (de) 2011-05-11 2016-07-13 New England Biolabs, Inc. Dna-polymerasevarianten mit verminderter exonukleaseaktivität und ihre anwendung
US8470573B2 (en) * 2011-06-21 2013-06-25 Bio-Rad Laboratories, Inc. Hybrid polymerases having the ability to produce long amplicons
EP2739752B1 (de) 2011-08-03 2017-07-19 Bio-Rad Laboratories, Inc. Filterung von kleinen nukleinsäuren anhand von permeabilisierten zellen
EP2914277B1 (de) 2012-11-02 2017-09-13 Celgene Corporation Activin-actrii-antagonisten und verwendungen zur behandlung von knochen- und anderen erkrankungen
EP2986719B1 (de) 2013-12-06 2020-07-29 Bio-Rad Laboratories, Inc. Fusionspolymerasen
CN114699529A (zh) 2014-06-13 2022-07-05 阿塞勒隆制药公司 用于治疗溃疡的方法和组合物
WO2016014493A1 (en) 2014-07-22 2016-01-28 Bio-Rad Laboratories, Inc. Buffers for use with polymerases
CN106661632B (zh) 2014-08-19 2021-11-05 生物辐射实验室股份有限公司 Rna扩增方法
MA41052A (fr) 2014-10-09 2017-08-15 Celgene Corp Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
CN108064278B (zh) 2014-11-14 2022-02-08 亿明达股份有限公司 聚合酶
EP3224359B1 (de) 2014-11-25 2023-10-25 Bio-Rad Laboratories, Inc. Arginin zur verbesserung der lagerstabilität von polymerase
TWI730949B (zh) 2014-12-03 2021-06-21 美商西建公司 活化素-ａｃｔｒｉｉ拮抗劑及治療貧血之用途
JP6736565B2 (ja) 2015-02-02 2020-08-05 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ポリメラーゼバリアント
EP3486329A1 (de) 2015-02-17 2019-05-22 Bio-Rad Laboratories, Inc. Verfahren zur erzeugung und amplifizierung von cdns
WO2017050723A1 (en) 2015-09-22 2017-03-30 Genia Technologies, Inc. Pol7 polymerase variants
CN108350087A (zh) * 2015-11-27 2018-07-31 国立大学法人九州大学 Dna聚合酶变体
CN116144626A (zh) 2016-01-13 2023-05-23 新英格兰生物实验室公司 T7 rna聚合酶的热稳定变体
US10273530B2 (en) 2016-01-15 2019-04-30 Thermo Fisher Scientific Baltics Uab Antibodies that bind thermophilic DNA polymerases
WO2017121836A1 (en) 2016-01-15 2017-07-20 Thermo Fisher Scientific Baltics Uab Thermophilic dna polymerase mutants
EP3423576B1 (de) 2016-02-29 2021-05-12 Genia Technologies, Inc. Polymerasevarianten
ES2882646T3 (es) 2016-02-29 2021-12-02 Genia Tech Inc Polimerasas carentes de actividad exonucleasa
EP3423574B1 (de) 2016-02-29 2021-03-17 Genia Technologies, Inc. Polymerase-template-komplexe zur nanoporensequenzierung
JP6720632B2 (ja) * 2016-03-29 2020-07-08 東洋紡株式会社 融合タンパク質
US10829747B2 (en) 2016-09-22 2020-11-10 Roche Sequencing Solutions, Inc. Polymerase variants
WO2019002178A1 (en) 2017-06-26 2019-01-03 Thermo Fisher Scientific Baltics Uab DNA MUTANTS THERMOPHILIC POLYMERASES
WO2019122200A1 (en) 2017-12-22 2019-06-27 Thermo Fisher Scientific Baltics Uab Polymerase chain reaction composition comprising amines
US11136565B2 (en) 2018-09-11 2021-10-05 Singular Genomics Systems, Inc. Modified archaeal family B polymerases
CN109266628B (zh) * 2018-10-09 2020-04-14 南京市胸科医院 一种融合的TaqDNA聚合酶及其应用
US10934533B1 (en) 2018-10-10 2021-03-02 New England Biolabs, Inc. Variant DNA polymerases having improved properties and method for improved isothermal amplification of a target DNA
CN109679932B (zh) * 2018-12-05 2020-03-17 广州奇辉生物科技有限公司 一种dna聚合酶、重组载体及它们的制备方法和应用
CN112175091A (zh) * 2019-07-05 2021-01-05 赛纳生物科技(北京)有限公司 通过功能结构域嫁接提高聚合酶大片段活性的方法及应用
US12163164B2 (en) 2019-07-15 2024-12-10 Bio-Rad Laboratories, Inc. Hybrid reverse transcriptases
US11512295B2 (en) 2019-09-12 2022-11-29 Singular Genomics Systems, Inc. Modified thermoccocus polymerases
KR20220125304A (ko) * 2020-01-06 2022-09-14 페어와이즈 플랜츠 서비시즈, 인크. 주형화된 편집을 위한 dna 폴리머라제의 동원
WO2021163561A1 (en) 2020-02-13 2021-08-19 New England Biolabs, Inc. Variant family d dna polymerases
WO2021163559A1 (en) 2020-02-13 2021-08-19 New England Biolabs, Inc. Variant family d dna polymerases
US20230086471A1 (en) * 2020-02-15 2023-03-23 Agency For Science, Technology And Research A method to amplify a nucleic acid
US11034942B1 (en) 2020-02-27 2021-06-15 Singular Genomics Systems, Inc. Modified pyrococcus polymerases and uses thereof
CN116209756A (zh) 2020-03-04 2023-06-02 旗舰先锋创新Vi有限责任公司 调控基因组的方法和组合物
CN111518873B (zh) * 2020-05-11 2024-07-09 上海羿鸣生物科技有限公司 一种优化的扩增目标核酸的方法及应用
PL241698B1 (pl) * 2021-01-27 2022-11-21 Inst Biotechnologii I Medycyny Molekularnej Polimeraza Pwo-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy
WO2022170212A1 (en) 2021-02-08 2022-08-11 Singular Genomics Systems, Inc. Methods and compositions for sequencing complementary polynucleotides
US11993792B2 (en) 2021-05-27 2024-05-28 New England Biolabs, Inc. DNase I variants, compositions, methods, and kits
WO2022250676A1 (en) 2021-05-27 2022-12-01 New England Biolabs, Inc. Dnase i variants, compositions, methods, and kits
EP4095254A3 (de) 2021-05-27 2022-12-14 New England Biolabs, Inc. Fragmentierung von dna
WO2022249133A1 (en) 2021-05-28 2022-12-01 Erebus Enzymes Inc. Ultra-processive, stutter-resistant polymerase system
IL311225A (en) 2021-09-08 2024-05-01 Flagship Pioneering Innovations Vi Llc Methods and compositions for genome modulation
EP4437090A1 (de) 2021-11-22 2024-10-02 F. Hoffmann-La Roche AG Thermostabile polymerasevarianten
EP4471162A4 (de) 2022-01-26 2025-12-17 Seegene Inc Verfahren zum nachweis von zielnukleinsäuren in einer probe
EP4524257A1 (de) 2022-05-13 2025-03-19 Seegene, Inc. Verfahren zur herstellung einer reaktionsmischung für eine nukleinsäureamplifikationsreaktion in einer probe unter verwendung eines probenhandhabungssystems
US20240263158A1 (en) 2023-02-01 2024-08-08 New England Biolabs, Inc. Duplex-specific dnases
WO2024244010A1 (zh) * 2023-06-02 2024-12-05 武汉华大智造科技有限公司 用于测序的dna聚合酶突变体
WO2025137293A2 (en) 2023-12-22 2025-06-26 Roche Sequencing Solutions, Inc. Enhancement of nucleic acid polymerization by aromatic compounds
WO2025227034A1 (en) 2024-04-26 2025-10-30 New England Biolabs, Inc. Salt active nuclease compositions and methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991008480A1 (en) 1989-12-01 1991-06-13 The Board Of Trustees Of The Leland Stanford Junior University Promotion of high specificity molecular assembly
US5747911A (en) 1994-09-30 1998-05-05 Itt Automotive Electrical Systems, Inc. Brush holder
US5972603A (en) * 1996-02-09 1999-10-26 President And Fellows Of Harvard College DNA polymerase with modified processivity
US6228628B1 (en) 1997-07-09 2001-05-08 Roche Molecular Systems Mutant chimeric DNA polymerase
DE19810879A1 (de) * 1998-03-13 1999-09-16 Roche Diagnostics Gmbh Polymerasenchimären
JP2002522042A (ja) * 1998-08-06 2002-07-23 ライオン バイオサイエンス アクチェンゲゼルシャフト ポリメラーゼ活性を有する熱安定性ｉｎｖｉｔｒｏ複合体
DE19840771A1 (de) * 1998-08-06 2000-02-10 Lion Bioscience Ag Thermostabiler in vitro-Komplex mit Polymeraseaktivität
EP1259624B1 (de) 2000-02-17 2008-05-14 Qiagen GmbH Thermostabile chimäre nucleinsäurepolymerasen und ihre verwendungen
US6627424B1 (en) 2000-05-26 2003-09-30 Mj Bioworks, Inc. Nucleic acid modifying enzymes

Also Published As

Publication number Publication date
US20150218536A1 (en) 2015-08-06
US20030148330A1 (en) 2003-08-07
JP2010000089A (ja) 2010-01-07
US6627424B1 (en) 2003-09-30
EP1283875A1 (de) 2003-02-19
US20030162173A1 (en) 2003-08-28
US20140038237A1 (en) 2014-02-06
EP1283875A4 (de) 2004-12-29
US20190078066A1 (en) 2019-03-14
EP1283875B1 (de) 2007-07-25
US7541170B2 (en) 2009-06-02
JP4405725B2 (ja) 2010-01-27
DE60129549T2 (de) 2008-04-24
US20040191825A1 (en) 2004-09-30
AU2001275039B2 (en) 2006-07-13
US20130203119A1 (en) 2013-08-08
CA2409417C (en) 2014-12-09
JP2003534796A (ja) 2003-11-25
US20170198267A1 (en) 2017-07-13
DK1283875T3 (da) 2007-11-26
DE60129549D1 (de) 2007-09-06
US9453208B2 (en) 2016-09-27
US10954495B2 (en) 2021-03-23
US8415129B2 (en) 2013-04-09
WO2001092501A1 (en) 2001-12-06
US8895283B2 (en) 2014-11-25
US20110165654A1 (en) 2011-07-07
US7670808B2 (en) 2010-03-02
CA2409417A1 (en) 2001-12-06
US8900846B2 (en) 2014-12-02
US7919296B2 (en) 2011-04-05
US10066218B2 (en) 2018-09-04
ES2291322T3 (es) 2008-03-01
AU7503901A (en) 2001-12-11

Similar Documents

Publication Publication Date Title
ATE368104T1 (de) Verbesserte nukleinsäure-modifizierende enzyme
ES2311638T3 (es) Metodos de empleo mejorado de polimerasa.
DE60042209D1 (de) Enzymatische synthese von deoxyribonucleotiden
ATE458832T1 (de) Paralleles scoring von polymorphismen mittels amplifikation und fehlerkorrektur
DE60036395D1 (de) Enzyme des auf die lysosomen gerichteten weges
DE60219579D1 (de) Reversibel modifizierte thermostabile Enzyme für die in vitro-Synthese und -Amplifizierung von DNA
DE60038886D1 (de) Neue enzyme, welche glycerin entwässern
BRPI0412328A (pt) aditivo de alimentos que compreende variantes exomilase não maltogênicas de pseudomonas
WO2003083054A8 (en) Amylases, nucleic acids encoding them and methods for making and using them
WO2002016583A3 (en) Constructs and their use in metabolic pathway engineering
MXPA03005548A (es) Metodos para la produccion de proteinas multimericas, y composiciones relacionadas.
NZ515673A (en) Compositions and methods for labeling of nucleic acid molecules
ES2166010T3 (es) Produccion de acrilato de amonio.
TR200101497T2 (tr) Lipolitik enzim varyantları
ATE346144T1 (de) Enzym mit galaktanaseaktivität
EP1832652A3 (de) Verbesserte Nukleinsäure-modifizierende Enzyme
ES2181897T3 (es) Composicion enzimatica.
ATE373102T1 (de) Verbessertes in-vitro-synthesesystem
ES2171136B1 (es) Enzima con actividad proteolitica construccion de adn que comprende una secuencia de adn que codifica dicha enzima y sus aplicaciones.
DE69728863D1 (de) Enzym mit pektin-esterase-aktivität
WO2001060986A3 (en) Esterase enzymes having selective activity
DE50008686D1 (de) Lytisches enzym
ATE402998T1 (de) D-hydantoinase aus ochrobactrum anthropi
DE60139701D1 (de) Identifzierung der cytotoxischen wirksamkeit von die tinte von aplysia punctata
DE69832606D1 (de) Acrylamidase-enzyme

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1283875

Country of ref document: EP